TCGA: Predicting Time to Ovarian Carcinoma Recurrence Using Protein Markers - Ji-Yeon Yang
TCGA: High-Grade Serous Ovarian Adenocarcinoma Transcriptome Sequencing - Andrew Mungall
Data Mining TCGA Breast and Ovarian Exomes for Novel Susceptibility Markers - John Martignetti
TCGA: Integrated Genomic Characterization of Endometrial Carcinoma - Douglas Levine
TCGA: Status Report and Insights From Leadership - Stephen Chanock
TCGA: Status Report and Insights From Leadership - Kenna Shaw
Kondrashova O (2019): Improving patient selection for PARP inhibitors in ovarian cancer
TCGA: Network-Based Stratification of Tumor Mutations - Matan Hofree
TCGA: Detection, Diagnosis and Correction of Batch Effects in TCGA Data - Rehan Akbani
Q&A: What is The Cancer Genome Atlas (TCGA)?
TCGA: Closing Remarks - Matthew Meyerson
TCGA: Genomic Characterization of Cancer-Adjacent Tissue - Melissa Troester
TCGA: Adverse Outcomes in Clear Cell Renal Cell Carcinoma With Mutations - Ari Hakimi
Dr. Levine on Sequencing of Agents for Ovarian Cancer
Dr. Ledermann on Phase III ARIEL3 Results in Ovarian Cancer
TCGA: Comprehensive Analysis of Lung Adenocarcinoma - Matthew Meyerson
Genetics and Ovarian Cancer Webinar
Validated Targets Associated With Curatively Treated Advanced Serous Ovarian... - Douglas Levine
TCGA: Assessing Tumor Heterogeneity and Tracking Clonal Evolution - Christopher Miller
TCGA: The Somatic Genomic Landscape of Glioblastoma Multiforme - Roel Verhaak
